X4 Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company based in Boston, Massachusetts, dedicated to pioneering innovative therapies for rare and serious diseases, with a particular focus on back disorders. The company's cutting-edge research leverages its proprietary biology to develop novel treatments aimed at improving patient outcomes. X4 is actively advancing its pipeline of investigational therapies through various phases of clinical development, positioning itself as a key player in the biopharmaceutical landscape. With a strong commitment to addressing unmet medical needs, X4 Pharmaceuticals is well-placed to contribute significantly to the evolving field of therapeutic solutions.
Click "Analyze" to generate stock analysis
XFOR Price Trend and Signals
XFOR Option Volumes & Open Interests (aggregated)
XFOR Put Call Ratios and IV (aggregated)
XFOR Financials
2025-10-28Somewhat Bullishprice_signal
Monthly high detected.
2025-10-24Bullishmacd_signal
Golden cross below zero detected.
2025-10-24Neutralvolume_signal
Abnormal volume detected compared to 5-day moving average.
2025-10-24Neutralvolume_signal
Abnormal volume detected compared to 10-day moving average.
2025-10-24Neutralvolume_signal
Abnormal volume detected compared to 20-day moving average.
2025-10-24Neutralvolume_signal
Abnormal volume detected compared to 3 mon moving average.